Are the milestone dates in Exhibit A deadlines tha
Post# of 30028
Nasdaq uplist - 30% 12/31/14
Eltoprazine US IND filed and approved for LID 30% 12/31/14
LymPro partner validation of analytical performance package (APP) and CLIA certification - 25% 12/31/14
MANF Orphan drug designation applications filed and approved for both ocular ischemic syndrome (OIA) and Retinitis pigmentosa - 15% 12/31/14